retatrutide phase 2 results obesity nejm 2023 Once-Monthly Maridebart Cafraglutide for the Treatment of — A Trial Daily Oral GLP-1 Receptor Agonist

GLP-1 Effects on Gastric Emptying GLP-1 receptor agonists delay gastric emptying, yet this effect lessens with prolonged use [116]

For broader metabolic support, learn more about peptide therapy in Tucson and longevity care

Cardiovascular Exercise Low to moderate-intensity cardio supports overall caloric expenditure and cardiovascular health

Months five through twelve typically show continued but decelerating weight loss

In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)